TOPLINE: Ritlecitinib demonstrates long-term improvements in regrowth of scalp hair, eyebrows, and eyelashes at 24 months in adults and adolescents with alopecia areata (AA) and ≥ 25% scalp hair loss. METHODOLOGY: Researchers evaluated outcomes in 449 de novo adult and adolescent patients (mean age, 32.9 years) with AA and ≥ 25% scalp hair loss, enrolled … Read more
TOPLINE: Patients with clinically node-negative breast cancer after neoadjuvant chemotherapy demonstrated low axillary and locoregional recurrence rates after sentinel lymph node biopsy (SLNB) or targeted axillary dissection. METHODOLOGY: More conservative treatment options for women with node-positive breast cancer include SLNB and targeted axillary dissection. However, data comparing patient outcomes after targeted axillary dissection and SLNB … Read more
Earlier initiation of digital screening mammography at age 40 years leads to substantial healthcare savings by reducing the cost of breast cancer treatment, according to a new cost-effectiveness study. Based on data in Canada for a population-based breast screening program, biennial screening for ages 40-74 years results in fewer deaths, more years of life for … Read more
Millions of American Women Skipping Crucial Breast Cancer Screenings Table of Contents Millions of American Women Skipping Crucial Breast Cancer Screenings study Reveals Alarming Gap in Mammogram Rates, Highlighting Disparities Disparities in Screening Rates Raise Concerns Access to Care: A Key Factor in Missed Screenings Bridging the Gap: A Call for Action Real Women, Real … Read more